Vitamin c and hiprex: a new hope against recurring UTIs?

NCT ID NCT06710899

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests whether adding vitamin C to the drug methenamine hippurate (Hiprex) helps prevent recurrent urinary tract infections (UTIs) in women. Twenty women will take either Hiprex alone or Hiprex plus vitamin C for six months each, and researchers will compare how many UTIs occur. The goal is to see if this simple combination works better than the drug alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Methenamine hippurate (Hiprex) with or without vitamin C
What this could lead to
If it works, this could point toward a simple, low-cost way to prevent recurrent urinary tract infections in women.
What could go wrong
This is a very early, small proof-of-concept study with only 20 participants. It may not show a clear benefit, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT URINARY TRACT INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospitals of North Midlands NHS Trust

    Stoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.